In short
The provided research passages do not define what "borderline resectable" means. They only use the term to describe a group of patients with pancreatic cancer who are eligible for certain clinical trials and treatments [1][2][3][4].
The details
The term appears in titles and study descriptions for patients with pancreatic ductal adenocarcinoma (PDAC) [2].
It is used alongside "resectable" to identify patients who may receive preoperative chemotherapy before surgery [2].
It is also used to describe patients with locally advanced disease who might be treated with specific drug combinations or ultrasound therapy [4].
One study mentions a need to redefine the term using biological markers like CA19-9 levels and lymph node status [3].
What to know
The passages do not explain the medical definition of "borderline resectable." They only show that this label is used to select patients for specific research studies. You should ask your doctor for a clear explanation of what this term means for your specific situation.
⚕️ This is for learning, not treatment decisions. Always talk with your oncology team — they know your full situation. The information here comes from published research and is meant to help you have better conversations with your doctors.